Control Bionics
- Short interest
- 0.02%
- +0.01 pp 30d
- as of 13 Aug 2026
- Reported shorts
- 105.1K
- Shares on issue
- 543.089M
Control Bionics (CBL) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $5.4MM (source: ASX (Markit))vs $7.0MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$7.3MM (source: ASX (Markit))vs −$6.1MM (source: ASX (Markit)) (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.020T (source: Derived: trailing 12 months at year end)vs −$0.023 (FY25)
- Derived: trailing 12 months at year end, as at 14 Oct 2026
- Rev YoY
- −23.3%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
- Derived: trailing 12 months at year end
Summary of Preliminary Final Report, 28 Aug 2026
Control Bionics reported a 22.4% decline in revenue to $4.77 million for FY2026, while its net loss widened by 18.9% to $7.27 million. No dividend was declared. The company acquired the remaining interest in Neuro Elite Athletics LLC during the year.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026
- Gross margin
- 46.9%
- Operating margin
- −140.6%
- Net margin
- −134.5%
- FCF margin
- −110.4%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- −151.7×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $5.4MM (source: ASX (Markit)) | $7.0MM (source: ASX (Markit)) | $5.1M | $5.4M |
| Gross profit | $2.5MT (source: Derived: trailing 12 months at year end) | n/a | $3.7M | $3.5M |
| Operating income | −$7.6MT (source: Derived: trailing 12 months at year end) | n/a | −$7.1M | −$6.3M |
| EBITDA | −$6.4MT (source: Derived: trailing 12 months at year end) | n/a | −$5.0M | −$5.1M |
| EBIT | −$7.2MT (source: Derived: trailing 12 months at year end) | n/a | −$5.9M | −$5.6M |
| Interest expense | $50.1KT (source: Derived: trailing 12 months at year end) | n/a | $56.3K | $12.3K |
| Pretax income | −$7.3MT (source: Derived: trailing 12 months at year end) | n/a | −$5.9M | −$5.6M |
| Tax | $0T (source: Derived: trailing 12 months at year end) | n/a | $0 | $0 |
| NPAT | −$7.3MM (source: ASX (Markit)) | −$6.1MM (source: ASX (Markit)) | −$5.9M | −$5.6M |
| Net interest income | −$78.7KT (source: Derived: trailing 12 months at year end) | n/a | −$44.1K | −$1.2K |
| EPS basic | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.023 | −$0.036 | −$0.055 |
| EPS diluted | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.023 | −$0.036 | −$0.055 |
| Shares | n/a | n/a | 202.8M | 102.1M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Preliminary Final ReportAnnual Results28 Aug 2026via asx_announcements
- 2026 Annual ReportAnnual Report28 Aug 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Jul 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report30 Apr 2026via asx_announcements
- Half Yearly Report and AccountsHalf Year Results26 Feb 2026via asx_announcements
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report28 Jan 2026via asx_announcements
- 2025 CBL Corporate GovernanceFinancial Report31 Dec 2025via crawler
- Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly Report31 Oct 2025via asx_announcements
- Annual Report to shareholdersAnnual Report12 Sep 2025via asx_announcements
- Preliminary Final ReportAnnual Results29 Aug 2025via asx_announcements
Showing 10 of 31 reports